首页> 外文期刊>Analytical and bioanalytical chemistry >FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease
【24h】

FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease

机译:FragClust和TestClust是用于脂质组学的化学结构层次聚类分析的两个信息学工具。阿尔茨海默氏病的例子

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Lipidomic analysis is able to measure simultaneously thousands of compounds belonging to a few lipid classes. In each lipid class, compounds differ only by the acyl radical, ranging between C10:0 (capric acid) and C24:0 (lignoceric acid). Although some metabolites have a peculiar pathological role, more often compounds belonging to a single lipid class exert the same biological effect. Here, we present a lipidomics workflow that extracts the tandem mass spectrometry data from individual files and uses them to group compounds into structurally homogeneous clusters by chemical structure hierarchical clustering analysis (CHCA). The case-to-control peak area ratios of the metabolites are then analyzed within clusters. We created two freely available applications to assist the workflow: FragClust to generate the tables to be subjected to CHCA, and TestClust to perform statistical analysis on clustered data. We used the lipidomics data from the plasma of Alzheimer's disease (AD) patients in comparison with healthy controls to test the workflow. To date, the search for plasma biomarkers in AD has not provided reliable results. This article shows that the workflow is helpful to understand the behavior of whole lipid classes in plasma of AD patients.
机译:脂质组学分析能够同时测量属于几种脂质类别的数千种化合物。在每种脂质类别中,化合物的区别仅在于酰基基团,介于C10:0(癸酸)和C24:0(木质酸)之间。尽管某些代谢物具有特殊的病理作用,但更常见的是属于单个脂质类别的化合物具有相同的生物学作用。在这里,我们介绍了一种脂质组学工作流程,该流程从单个文件中提取串联质谱数据,并使用它们通过化学结构层次聚类分析(CHCA)将化合物分组为结构上均一的簇。然后在簇内分析代谢物的病例对照峰面积比。我们创建了两个免费的应用程序来辅助工作流程:FragClust生成要经受CHCA的表,以及TestClust来对集群数据进行统计分析。我们将来自阿尔茨海默氏病(AD)患者血浆的脂质组学数据与健康对照组进行比较,以测试工作流程。迄今为止,在AD中寻找血浆生物标志物尚未提供可靠的结果。本文表明,该工作流程有助于理解AD患者血浆中全脂类的行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号